Bacil Pharma Ltd — Important, 24-02-2026: Company Update

Bacil Pharma Limited responded to the stock exchange regarding recent significant price and trading volume movements in its securities. The company clarified it possesses no undisclosed price-sensitive information or material developments that could influence these movements. It confirmed timely disclosure of all required information and believes the fluctuations are purely market-driven. Bacil Pharma reiterates its commitment to high corporate governance and transparency.